Navigation Links
Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection
Date:2/6/2012

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the voluntary recall of a single lot of OFIRMEV® (acetaminophen) injection. Cadence has notified the U.S. Food and Drug Administration of the recall.

The recall of OFIRMEV lot number V005710 was initiated due to the presence of an unidentified, visible particle in one vial of this lot during routine stability testing.  Lot V005710 was distributed by Cadence to hospitals, wholesalers and distributors beginning in January 2011, and Cadence believes that fewer than 1,000 vials currently remain in the marketplace. Cadence has not received any reports of adverse patient events associated with particulate matter in the product, and has undertaken the recall as a precautionary measure.  

"We regret that some of our customers experienced short-term supply delays due to our temporary suspension of shipments from the supplier of lot V005710," said Scott Byrd, Chief Commercial Officer of Cadence. "Fortunately, we were successful in our efforts to accelerate shipments of OFIRMEV from another supplier, which allowed us to quickly resume normal shipments of the product. We do not anticipate any further supply delays."

Customer Recall ContactCustomers with questions regarding this recall should call 1-866-338-4070.About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
2. Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
3. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
6. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
7. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
9. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
10. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
11. Cadence, Inc. Announces Major Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Richmond Pharmacology is ... with a worldwide reputation for excellence in clinical ... in peer reviewed medical journals. Its officers are ... in discussions about rules for transparency and publication ... http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research is conducted ...
(Date:5/21/2015)...  When Ryan Rendino first felt the ... neck, he figured it was a muscle ... from weight lifting. But the ... A series of doctor appointments followed ... Michel Kliot, MD , a Northwestern ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... of Obstetricians and Gynecologists (ACOG) and Society for ... and ensure that healthcare providers, patients, and the ...  The information update from ACOG and SMFM confirms ...
... MONTREAL, Oct. 13, 2011 A Medco Health Solutions, ... found that 38 percent of patients prescribed Plavix® (clopidogrel)—an ... and stroke—were also using another drug that would impede ... The analysis also showed that primary care physicians ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4
(Date:5/22/2015)... A new program for the "In America" television series ... Therapy. , James Earl Jones will host the ... therapy and discusses how the exercises can decrease pain ... ailments and injuries. Physical therapists work with their ... daily activities such as house cleaning and shopping, work ...
(Date:5/22/2015)... 2015 Javon Bea Mercy Health ... for providing the highest quality emergency care services, especially ... decision-making,” said Javon R. Bea, President and CEO of ... our employee/partners to care for and respond to what ... not apply for this award, but are selected if ...
(Date:5/21/2015)... 2015 WellCare Health Plans, Inc. (NYSE: WCG) ... by the Florida Healthy Kids Corporation (FHKC) to continue to ... as part of the Florida Healthy Kids (FHK) program. Pending ... and may be extended for two additional years at FHKC’s ... in the FHK program who live in Regions 1, 2, ...
(Date:5/21/2015)... How do you stop head lice epidemics in schools? This ... but a Miami Lice Removal Company, Lice Troopers, the ... devising new ways to stop the spread. , As ... step is education and prevention. Despite the ubiquity of head ... spread are still widely misunderstood. Many continue to equate the ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Many probiotics ... effect on those with celiac disease according to a ... half of the probiotics tested in the study contained ... and dietary supplements and cause gastrointestinal inflammation for those ... aiming to gain consumer trust in gluten-free claims have ...
Breaking Medicine News(10 mins):Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4
... deaths in the United States are linked to behavioral and ... these causal links, of the $2 trillion spent annually on ... is devoted to addressing behavioral and social risk factors. ... and social sciences with a new $500,000 grant from the ...
... between the social impairments found in autism and schizophrenia ... disorders. Autism spectrum disorder (ASD) and schizophrenia are ... in social dysfunction. For many years, this similarity resulted ... were thought to have a childhood version of schizophrenia, ...
... with pancreatic cancer may be one step closer to ... in some cases but not in others, according to ... of the American Association for Cancer Research. ... medicine at the University of Cambridge, utilized a laboratory ...
... , TUESDAY, Feb. 28 (HealthDay News) --,Vegetarians ... cultural reasons may unknowingly be consuming gelatin derived ... new study found. Animal-derived gelatin is a commonly ... used as a thickener in some liquid and semisolid ...
... 2012) A great deal has been learned in the ... Health Initiative (WHI). Hormone therapy (HT) remains the most effective ... there is a growing body of evidence that formulation, route ... produce different effects. It is essential to evaluate ...
... study headed up by the Vall d,Hebron Institute of Oncology ... opening up a parallel dimension to existing treatment options. The ... , demonstrate that by combining two drugs that had already ... stopped working, they boost each other,s efficacy and at the ...
Cached Medicine News:Health News:Training grant targets behavioral and social factors linked to health 2Health News:Training grant targets behavioral and social factors linked to health 3Health News:Study compares traits of autism, schizophrenia 2Health News:Many Vegetarians Unaware of Animal-Derived Gels in Pills 2Health News:The North American Menopause Society (NAMS) reassures many women 2Health News:A giant little step in cancer treatment opening up new therapeutic horizons 2
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Speculum with malleable plate to support flap during ablation of thestromal bed....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Angled 45 degrees....
Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: